PROCEEDINGS VOLUME 6427
SPIE BIOS | 20-25 JANUARY 2007
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI
IN THIS VOLUME

0 Sessions, 36 Papers, 0 Presentations
Localization  (3)
ALA  (3)
Clinical PDT  (2)
Dosimetry  (3)
Imaging  (1)
SPIE BIOS
20-25 January 2007
San Jose, California, United States
Front Matter 6427
Proc. SPIE 6427, Front Matter: Volume 6427, 642701 (26 March 2007); doi: 10.1117/12.730345
Signaling Pathways
Proc. SPIE 6427, PDT: death pathways, 642702 (9 February 2007); doi: 10.1117/12.702441
Proc. SPIE 6427, Initial targets and cellular responses to PDT, 642703 (27 February 2007); doi: 10.1117/12.717011
Proc. SPIE 6427, Tumor cell hyperresistance to photodynamic killing arising from nitric oxide preconditioning, 642705 (27 February 2007); doi: 10.1117/12.701334
Localization
Proc. SPIE 6427, Optical molecular imaging in PDT, 642706 (6 March 2007); doi: 10.1117/12.698688
Proc. SPIE 6427, Correlation between cell viability and cumulative singlet oxygen luminescence from protoporphyrin IX in varying subcellular localizations, 642707 (27 February 2007); doi: 10.1117/12.700674
Proc. SPIE 6427, Macroscopic modeling of the singlet oxygen production during PDT, 642708 (6 March 2007); doi: 10.1117/12.701387
New Sensitizers
Proc. SPIE 6427, Syntheses and cellular studies of water soluble porphyrin-peptide conjugates, 64270A (27 February 2007); doi: 10.1117/12.698445
Proc. SPIE 6427, Fractionation of the Hypericum perforatum L. extract: PMF, and PDT effects of the fractions against HL-60 leukemic cells, 64270B (27 February 2007); doi: 10.1117/12.700981
ALA
Proc. SPIE 6427, Improved murine glioma detection following modified diet and photobleaching of skin PpIX fluorescence, 64270D (27 February 2007); doi: 10.1117/12.700456
Proc. SPIE 6427, Hyperbaric oxygen therapy augments the photodynamic action of methylene blue against bacteria in vitro, 64270F (27 February 2007); doi: 10.1117/12.701046
Proc. SPIE 6427, Characterization of time-domain fluorescence properties of typical photosensitizers for photodynamic therapy, 64270G (8 March 2007); doi: 10.1117/12.697638
Clinical PDT
Proc. SPIE 6427, Effect of implanted brachytherapy seeds on optical fluence distribution: preliminary ex vivo study, 64270J (27 February 2007); doi: 10.1117/12.700756
Proc. SPIE 6427, A method to improve reconstruction of the distribution of hemoglobin, oxygenation, and MLu concentration in the human prostate before and after photodynamic therapy, 64270K (27 February 2007); doi: 10.1117/12.699545
Dosimetry
Proc. SPIE 6427, Conformal light delivery using tailored cylindrical diffusers, 64270M (27 February 2007); doi: 10.1117/12.700996
Proc. SPIE 6427, Modeling light fluence rate distribution in optically heterogeneous prostate photodynamic therapy using a kernel method, 64270N (27 February 2007); doi: 10.1117/12.702798
Proc. SPIE 6427, Interstitial photodynamic therapy for primary prostate cancer incorporating real-time treatment dosimetry, 64270O (27 February 2007); doi: 10.1117/12.699903
Vascular Responses
Proc. SPIE 6427, In vivo on-line monitoring of molecular response to photodynamic therapy: molecular imaging of vascular endothelial growth factor, 64270P (8 March 2007); doi: 10.1117/12.706605
Proc. SPIE 6427, Two-photon photodynamic therapy and its potential application to age related macular degeneration, 64270R (27 February 2007); doi: 10.1117/12.701086
Proc. SPIE 6427, Tumor vascular volume determines photosensitizer uptake in MATLyLu prostate tumor model, 64270S (27 February 2007); doi: 10.1117/12.699033
Imaging
Proc. SPIE 6427, Pharmacokinetic study of a systemically administered novel liposomal Temoporfin formulation in an animal tumor model, 64270T (27 February 2007); doi: 10.1117/12.698932
Poster Session
Proc. SPIE 6427, New near-infrared photosensitizers based on bacteriochlorin p derivatives: preliminary results of in vivo investigations, 64270W (28 February 2007); doi: 10.1117/12.697411
Proc. SPIE 6427, Phenylthio-substituted phthalocyanines as new photosensitizers for photodynamic therapy, 64270X (13 March 2007); doi: 10.1117/12.697426
Proc. SPIE 6427, Blood porphyrin luminescence and tumor growth correlation, 64270Y (6 March 2007); doi: 10.1117/12.698366
Proc. SPIE 6427, Monte Carlo simulation of elastic-scattering spectroscopic measurement using the optical pharmacokinetic system (OPS): analysis of sensitivity to heterogeneous chromophore distribution, 642710 (28 February 2007); doi: 10.1117/12.699137
Proc. SPIE 6427, Fluence rate variability among light delivery devices for esophageal photodynamic therapy, 642712 (28 February 2007); doi: 10.1117/12.699541
Proc. SPIE 6427, Development of high-yielding photonic light delivery system for photodynamic therapy of esophageal carcinomas, 642713 (28 February 2007); doi: 10.1117/12.699590
Proc. SPIE 6427, Analysis of colon tumors in rats by near-infrared Raman spectroscopy, 642714 (28 February 2007); doi: 10.1117/12.699690
Proc. SPIE 6427, The measurement of the phosphorescence and singlet oxygen fluorescence time-resolved waveforms of Photofrin(II) and Talaporfin sodium with pulsed excitation, 642715 (28 February 2007); doi: 10.1117/12.699857
Proc. SPIE 6427, Infrared light utilized for photodynamic therapy by activation of rare earth phosphors for visible light generation, 642717 (28 February 2007); doi: 10.1117/12.700252
Proc. SPIE 6427, In vitro study on methemoglobin formation in erythrocytes following hexyl-aminolevulinate induced photodynamic therapy, 642719 (8 March 2007); doi: 10.1117/12.700993
Proc. SPIE 6427, Enhancing PDT drug delivery by enzymatic cleavage of porphyrin phosphates, 64271A (28 February 2007); doi: 10.1117/12.701185
Proc. SPIE 6427, A versatile nanocrystal-based multi-sensory fiber-optic probe for dosimetry in PDT and thermal treatment, 64271B (28 February 2007); doi: 10.1117/12.701274
Proc. SPIE 6427, Photodynamic therapy (PDT) using intratumoral injection of the 5- aminolevulinic acid (5-ALA) for the treatment of eye cancer in cattle, 64271C (28 February 2007); doi: 10.1117/12.701316
Proc. SPIE 6427, The apoptosis induced by HMME-based photodynamic therapy in rabbit vascular smooth muscle cells, 64271F (28 February 2007); doi: 10.1117/12.702042
Proc. SPIE 6427, The dual effects of polar methanolic extract of Hypericum perforatum L. in bladder cancer cells, 64271G (13 March 2007); doi: 10.1117/12.727003
Back to Top